Pharmaceutical composition for treating nervous system disease comprising human blood derived hematosphere

摘要

The present invention provides a pharmaceutical composition for the treatment of neurological diseases including hematopoietic cells derived from human blood. More specifically, the present invention relates to a novel cell therapy agent capable of treating neurological diseases by inducing neural progenitor cells and neurons through effective three-dimensional culture using blood mononuclear cells and ultimately enabling efficient differentiation into neurons It is expected to be used for